Looking at the direction of medical equipment development in the next 15 years through "Healthy China 2030"

According to the news of Xinhua News Agency on October 25, the Central Committee of the Communist Party of China and the State Council recently issued the "Outline of the "Healthy China 2030" Plan" and issued a notice requesting all departments of various regions to conscientiously implement it in light of the actual situation.

The "Planning Outline" proposes that by 2030, China's main health indicators will enter the ranks of high-income countries, and the average life expectancy of the people will increase by about 3 years to 79 years. The overall strength of health science and technology innovation ranks among the top strategic targets in the world.

The "Planning Outline" has also given detailed guidance on giving full play to the unique advantages of traditional Chinese medicine, deepening the reform of the medical device circulation system, strengthening the supervision of pharmaceuticals, optimizing the pattern of multiple medical treatments, strengthening medical technology innovation, and promoting the application of health care big data.

The "Healthy China 2030" planning outline is the action plan for promoting healthy China construction in the next 15 years. It was reviewed and approved by the Political Bureau of the CPC Central Committee on August 26 this year. Its importance can be imagined. It can be said that it is the most in the field of medical health. The design of the top layer.

The passage and public release of the "Planning Outline" also means that a series of related policies will be introduced.

In the new stage of China's economic development entering the consumption and service industry, the implementation of the "Planning Outline" will drive a new round of growth in the health care industry clusters such as medical devices, pharmaceuticals, medical insurance and pensions. At present, the construction of “healthy China” has risen to a national strategy. Some institutions expect that the scale of the health care industry around the "health health, great health and big medicine" during the "13th Five-Year Plan" period is expected to reach the order of 10 trillion yuan.

For the medical device industry, the "Planning Outline" has also made many clear instructions. mainly include:

Deepen the reform of medical device circulation system

The "Planning Outline" proposes to promote the extension of pharmaceutical and medical device circulation enterprises to the upstream and downstream of the supply chain to form a new modern circulation system. We will implement the status of procurement of pharmaceuticals and consumables in medical institutions and encourage joint procurement. We will build a modern pharmaceutical distribution network throughout the urban and rural areas to improve the supply of medicines at the grassroots and remote areas.

Medical equipment review and approval standards have been greatly improved

The "Planning Outline" proposes to deepen the reform of the drug and medical (medical device) review and approval system, to establish a clinical efficacy-oriented examination and approval system, and to improve the drug (medical device) approval standards. Accelerate the review and approval of innovative drugs (medical devices) and clinically urgently needed new drugs (medical devices), and promote the consistency evaluation of generic drugs' quality and efficacy. We will improve the national drug standards system, implement the medical device standard improvement plan, and actively promote the internationalization of Chinese medicine (material) standards. Comprehensively strengthen drug supervision and form a chain of supervision for the whole variety and the whole process. Strengthen the supervision of medical devices and cosmetics.

Accelerate the transformation and upgrading of medical devices

The "Planning Outline" proposes to improve the collaborative innovation system for government, industry, research and research, and promote pharmaceutical innovation and transformation and upgrading. include:

1. Strengthen the construction of innovative capabilities such as patented drugs, new Chinese medicines, new preparations, and high-end medical devices, and promote the imitation of patent-expired drugs for the treatment of major diseases.

2. Vigorously develop new varieties of biopharmaceuticals, chemical drugs, high-quality Chinese medicines, high-performance medical devices, new auxiliary materials and pharmaceutical equipment, promote the industrialization of major drugs, accelerate the transformation and upgrading of medical devices, and improve medical diagnostic equipment with independent intellectual property rights. The international competitiveness of medical materials.

3. Accelerate the development of the rehabilitation aids industry and enhance the capacity for independent innovation.

4. Improve the quality standard system, improve the quality control technology, implement green and intelligent transformation and upgrading, and by 2030, the quality standards for pharmaceuticals and medical devices will be fully integrated with the international standards.

The localization rate of high-end medical equipment has increased significantly

The "Planning Outline" proposes to enhance the supply capacity of high-end products in pharmaceutical manufacturing and improve the international competitiveness of pharmaceutical companies.

In particular, by 2030, the international market share of new drugs and medical equipment with independent intellectual property rights has increased substantially, and the localization rate of high-end medical equipment market has increased substantially, achieving rapid development in the pharmaceutical industry and moving toward the middle and high-end, and entering the ranks of the world's pharmaceutical powers.

In addition, we will promote the transformation and upgrading of the pharmaceutical circulation industry, reduce circulation links, increase the concentration of the circulation market, and form a group of large-scale multinational pharmaceutical distribution enterprises.

Focus on the deployment of localization of medical devices

The "Planning Outline" proposes to "promote medical science and technology progress." include:

1. Launch and implement major scientific and technological projects and major projects such as brain science and brain research, health protection, and promote scientific and technological plans for major national science and technology projects and key national key research and development programs.

2. Develop cutting-edge technologies such as omniscience technology, stem cell and regenerative medicine, new vaccines, and biological therapy, strengthen key technologies such as prevention and control of chronic diseases, precision medicine, and smart medical care, and focus on the development of innovative drug development, localization of medical devices, and Tasks such as medical modernization have significantly enhanced the scientific and technological support capabilities for major disease prevention and health industry development.

3. Strive to reach the international forefront of the influence of scientific papers and the total number of patents of the three parties by 2030, and further increase the contribution rate of scientific and technological innovation to the growth of the pharmaceutical industry and the conversion rate of results.

Explore and advance the development of wearable devices

The "Planning Outline" proposes to develop Internet-based health services, encourage the development of health services such as health checkups and consultations, promote the development of personalized health management services, foster a number of distinctive health management service industries, and explore the promotion of wearable devices and smart health. Development of electronic products and health care mobile application services.

Guide the development of the "Four Centers"

The "Planning Outline" proposes to guide the development of professional medical testing centers, medical imaging centers, pathological diagnosis centers and hemodialysis centers. Support the development of third-party medical service evaluation, health management service evaluation, and health market research and consulting services. Encourage social forces to provide food and drug testing services. Improve the technology intermediary system and vigorously develop specialized, market-oriented medical technology achievements transformation services.

As can be seen from the above, the localization and quality upgrade of medical devices, technological innovation, and procurement of medical consumables will become the focus of national policy for a long time to come. For the insiders, it is only by grasping the policy trends that they can better develop for themselves.

In addition, for the medical industry's most concerned medical insurance reform, the "Planning Outline" also made clear instructions.